uracil has been researched along with Amyloid Deposits in 1 studies
2,4-dihydroxypyrimidine: a urinary biomarker for bipolar disorder
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Semenov, VE | 3 |
| Zueva, IV | 3 |
| Lushchekina, SV | 3 |
| Suleimanov, EG | 3 |
| Gubaidullina, LM | 3 |
| Shulaeva, MM | 3 |
| Lenina, OA | 3 |
| Petrov, KA | 3 |
1 other study available for uracil and Amyloid Deposits
| Article | Year |
|---|---|
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |
Novel Uracil-Based Inhibitors of Acetylcholinesterase with Potency for Treating Memory Impairment in an Animal Model of Alzheimer's Disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Benzoates; Disease Models, Animal; Memory Disorder | 2022 |